✦ LIBER ✦

POS5: PREVALENCE OF PHARMACOTHERAPY FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS IN A MANAGED CARE ENVIRONMENT

✍ Scribed by J Hall; M Nelson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of compliance with osteoporos

✍ Krista F. Huybrechts; Khajak J. Ishak; J. Jaime Caro 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Osteoporosis Prevalence and Levels of Tr

✍ John Eisman; Sharon Clapham; Linda Kehoe 📂 Article 📅 2004 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 91 KB

17 PREVENTION AND TREATMENT OF POSTMENOP

✍ Franic, D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB

PMS9 Prevalence of Shoulder Osteoarthist

✍ C.M. Kozma; S.K. Bhattacharyya; P. Palazola 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Etidronate Therapy in the Treatment and

✍ Hanley, David A.; Ioannidis, George; (Rick) Adachi, J.D. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 109 KB

PUK17 PREVALENCE, DEMOGRAPHICS, AND PHAR

✍ G Daniel; SA Kamat; K Brewer; MF Bullano; T Telly; T Williamson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB